Vidal A. Febles
NPI 1578528634ActiveIndividual· Internal Medicine· Penuelas, PR
Internal Medicine in Penuelas, Puerto Rico, licensed in PR, with an NPI issued in April 2006. Part D covered 13,434 prescriptions written in 2024, 86% of them generic. Glaxosmithkline, LLC. was the largest of 2 companies reporting payments in 2025, $94.46 in all, mostly food and beverage.
Overview
| NPI | 1578528634 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | Yes |
| NPI issued | Apr 19, 2006 |
| Last updated in NPPES | Nov 16, 2010 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine Primary | 207R00000X | 8993 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Internal Medicine (PR) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 13,434 · 20,291 30-day fills |
|---|---|
| Patients | 454 |
| Total drug cost | $647,759 |
| Generic share | 86% of claims |
Industry payments (Open Payments)
- 2025$94.46 · 2 payments from 2 companies
- 2024$15.56 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $51.30 | 1 |
| Genzyme Corporation | $43.16 | 1 |
What the 2025 payments were for
- Food and Beverage$94.46 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine providers in Penuelas
- 1053920967
- 1013073857
- 1891752440